Research Article
Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection
Table 1
Demographic and clinical characteristics of the study population.
| | Age (years) | Mean (SD): 46.96 (9.61) | | Median range: 46 (41–52) |
| | Sex (%) | Male: 219 (73) | | Female: 81 (27) |
| | Ethnic background (%) | White: 253 (84.3) | | Hispanic: 27 (9) | | Black: 9 (3) |
| | Risk group (%) | IDU: 110 (36.7) | | MSM: 106 (35.3) | | Heterosexual: 74 (24.7) | | Others: 7 (3.3) |
| | HAART (%) | Yes: 283 (95.3) | | No: 17 (4.7) | | NNRTI: 130 (43.3) | | PI: 165 (55) | | TDF: 173 (57.5) | | ABC: 63 (21) |
| | Serum 25(OH)D category (%) | <10 ng/mL: 84 (28) | | <20 ng/mL: 186 (62) | | >20 ng/mL: 114 (38) |
| | PTH > 65 pg/mL (%) | Yes: 137 (45.7) | | No: 163 (54.3) |
|
|
